Dergiler / Gülhane Tıp Dergisi / 2019 / Cilt: 61 - Sayı: 4

Treatment response of sofosbuvir in HCV virus/ Helicobacter pylori co-infected patient a case report

Sayfa
189–191
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Newly developed direct-acting anti-viral drugs act as a major breakthrough in the area of HCV therapeutics.
📊
Temel Bulgular & Veri:Accumulating evidence suggest that more than 99% patients achieve sustained virological response after receiving sofosbuvir-based therapy.
💡
Sonuç & Katkı:However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Newly developed direct-acting anti-viral drugs act as a major breakthrough in the area of HCV therapeutics. Accumulating evidence suggest that more than 99% patients achieve sustained virological response after receiving sofosbuvir-based therapy. However, we observed the first case of DAA treatment failure in HCV patient who was co-infected with H. Pylori.

🔖

Bu Makaleye Atıf Yap

WAHID, B. (2019). Treatment response of sofosbuvir in HCV virus/ Helicobacter pylori co-infected patient a case report. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 4, 189–191. https://ajindex.com/articles/161840

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet. 2013; 380(9859):2095-2128
  2. Rocha M, Avenaud P, Menard A, et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut. 2005; 54(3):396-401
  3. Waluga M, Kukla M, Żorniak M, Bacik A, Kotulski R. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol. 2015; 7(18):2136-2146
  4. Dogan Z, Filik L, Ergül B, Sarikaya M, Akbal E. Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study. Eur J Gastroenterol Hepatol. 2013; 25(1):107-110
  5. Fabbri G, Mastrorosa I, Vergori A, et al. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature. BMC Infect Dis. 2017; 17(1):182-187
  6. Fernández-Carrillo C, Londoño M-C, Arias-Loste T, et al. Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents. Clin Gastroenterol Hepatol. 2016; 14(11):1662-1666
  7. Takayama H, Sato T, Ikeda F, Fujiki S. Reactivation of hepatitis B virus during interferon-free therapy with daclatasvir and asunaprevir in patient with hepatitis B virus/hepatitis C virus co-infection. Hepatol Res. 2015; 46(1):489-491
  8. Zandman D, Hahn W, Moss S. A Case of Persistent Helicobacter pylori infection occurring with anti-IgE immunosuppression. ACG Case Rep J. 2013; 1(1):16-18
  9. Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis. 1997; 25(5):973-978
  10. Queiroz DMM, Rocha AMC, Rocha GA, et al. Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus. Digestive Dis Sci. 2006; 51(2):370-373
  11. Taylor N, Fox J, Yan L. In-vitro hepatotoxic factor in Helicobacter hepaticus, H. pylori and other Helicobacter species. J Med Microbiol. 1995; 42(1):48-52
  12. Foster GR, Pianko S, Brown A, et al. Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. Gastroenterol. 2015; 149(6):1462-1470.